JRS PHARMA revealed plans to build a new manufacturing plant in Cedar Rapids, Iowa. The facility, a two-story pre-cast building, will start construction in fall 2022 and begin operations in early 2024, producing microcrystalline Cellulose products.
Roquette Freres S.A. a renowned global provider of plant-based ingredients and a top supplier of pharmaceutical and neutraceutical excipients, has announced the full acquisition of Crest Cellulose, an excipient manufacturer based in India.
Author Credits: Smruti Ranjan, Rajrani Baghel
Report ID: 4614
Published Date: Sep 27, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The expansion of the chemical industry worldwide, and the growing food & beverages industry are some major factors driving the growth of the market.
The market size of microcrystalline cellulose is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024 â€“ 2036.
The major players in the market are Rayonier Advanced Materials, Roquette, DFE Pharma GmbH & Co.KG, JRS Pharma GmbH & Co.KG, Avantor Performance Materials Inc., Gujarat Microwax Limited, Sigachi Industrial Pvt. Ltd, FMC Corporation, Accent Microcell Pvt. Ltd, and others.
The non-wood-based segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the Europe region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.